Back to News
Market Impact: 0.45

New Strong Sell Stocks for July 10th

DECKBIOELUXY
Corporate EarningsAnalyst EstimatesAnalyst InsightsCompany Fundamentals
New Strong Sell Stocks for July 10th

Zacks has designated BioRad Laboratories (BIO), Deckers Outdoor (DECK), and Electrolux (ELUXY) as "Strong Sell" (Zacks Rank #5) stocks, citing significant downward revisions in their current year earnings estimates. Over the past 60 days, BioRad's estimates fell 6.7%, Deckers' 6.4%, and Electrolux's 5%, signaling a deteriorating earnings outlook for these companies.

Analysis

Zacks has issued a "Strong Sell" rating (Rank #5) for BioRad Laboratories (BIO), Deckers Outdoor (DECK), and Electrolux (ELUXY), signaling a significant negative shift in their near-term outlook. This bearish stance is directly attributed to substantial downward revisions in their respective Zacks Consensus Estimates for current year earnings over the past 60 days. Specifically, BioRad's earnings estimate has been reduced by 6.7%, Deckers Outdoor's by 6.4%, and Electrolux's by 5%. Such material revisions indicate a deteriorating fundamental picture and a strong analyst consensus that these companies are likely to underperform the broader market in the coming months.

AllMind AI Terminal

AI-powered research, real-time alerts, and portfolio analytics for institutional investors.

Request a Demo

Market Sentiment

Overall Sentiment

strongly negative

Sentiment Score

-0.65

Ticker Sentiment

BIO-0.70
DECK-0.70
ELUXY-0.70

Key Decisions for Investors

  • Given the Zacks #5 'Strong Sell' rating and significant downward earnings revisions, investors holding BioRad (BIO), Deckers (DECK), or Electrolux (ELUXY) should re-evaluate their positions for potential near-term underperformance.
  • The deteriorating earnings outlook for all three companies suggests that initiating new long positions may carry elevated risk until there is evidence of fundamental stabilization or a positive shift in analyst estimates.
  • Traders with a bearish thesis might consider these analyst downgrades as a catalyst for potential short-selling opportunities, contingent on their own risk tolerance and further due diligence.